These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15090928)

  • 1. Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience.
    Fernandez HH; Trieschmann ME; Friedman JH
    Clin Neuropharmacol; 2004; 27(1):4-5. PubMed ID: 15090928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole in psychosis associated with Parkinson's disease.
    López-Meza E; Ruiz-Chow A; Ramirez-Bermudez J
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):421-2. PubMed ID: 16179668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
    Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
    Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of atypical antipsychotics in elderly patients with dementia.
    Tariot PN; Profenno LA; Ismail MS
    J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aripiprazole induced Parkinsonism: A case report].
    Pasquier de Franclieu S; Germain C; Petitjean F
    Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary microadenoma treated with antipsychotic drug aripiprazole.
    Wix-Ramos RJ; Paez R; Capote E; Ezequiel U
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):58-60. PubMed ID: 22074578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole.
    Madhusoodanan S; Shah P
    Clin Interv Aging; 2008; 3(3):491-501. PubMed ID: 18982919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole and Parkinson's disease psychosis.
    Schönfeldt-Lecuona C; Connemann BJ
    Am J Psychiatry; 2004 Feb; 161(2):373-4. PubMed ID: 14754792
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
    Pérez-Iglesias R; Ortiz-Garcia de la Foz V; Martínez García O; Amado JA; Garcia-Unzueta MT; Ayesa-Arriola R; Suarez-Pinilla P; Tabares-Seisdedos R; Crespo-Facorro B
    Schizophr Res; 2014 Oct; 159(1):90-4. PubMed ID: 25151200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe exacerbation of psychosis after sudden withdrawal of chlorpromazine in the treatment of methamphetamine-associated psychosis with aripiprazole and chlorpromazine: 2 case reports.
    Wang G; Devi Thakoor JP; Wang X; Hao W
    J Addict Med; 2014; 8(6):479-81. PubMed ID: 25303986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aripiprazole: a new atypical antipsychotic drug].
    Fischer B; Davids E; Gastpar M
    Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole: profile on efficacy and safety.
    Goodnick PJ; Jerry JM
    Expert Opin Pharmacother; 2002 Dec; 3(12):1773-81. PubMed ID: 12472374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does aripiprazole have a role in treating cognitive impairment in Parkinson's disease?
    Singh Ajit S
    J Neuropsychiatry Clin Neurosci; 2007; 19(2):205-6. PubMed ID: 17431080
    [No Abstract]   [Full Text] [Related]  

  • 18. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic.
    Keck PE; McElroy SL
    Expert Opin Investig Drugs; 2003 Apr; 12(4):655-62. PubMed ID: 12665420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole, a novel atypical antipsychotic drug.
    Argo TR; Carnahan RM; Perry PJ
    Pharmacotherapy; 2004 Feb; 24(2):212-28. PubMed ID: 14998222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication.
    Pae CU; Kim TS; Lee C; Paik IH
    J Neuropsychiatry Clin Neurosci; 2005; 17(4):558. PubMed ID: 16388000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.